Envestnet Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$54.3M Sell
103,422
-13,305
-11% -$6.98M 0.02% 715
2025
Q1
$74M Buy
116,727
+25,589
+28% +$16.2M 0.02% 562
2024
Q4
$64.9M Buy
91,138
+10,060
+12% +$7.17M 0.02% 600
2024
Q3
$85.2M Buy
81,078
+5,626
+7% +$5.91M 0.03% 524
2024
Q2
$79.3M Buy
75,452
+8,209
+12% +$8.63M 0.03% 507
2024
Q1
$64.7M Buy
67,243
+3,760
+6% +$3.62M 0.02% 569
2023
Q4
$55.8M Buy
63,483
+5,794
+10% +$5.09M 0.02% 573
2023
Q3
$47.5M Sell
57,689
-5,133
-8% -$4.22M 0.02% 595
2023
Q2
$45.1M Sell
62,822
-1,853,952
-97% -$1.33B 0.02% 567
2023
Q1
$50.5M Buy
1,916,774
+1,848,784
+2,719% +$48.7M 0.02% 501
2022
Q4
$49.1M Sell
67,990
-10,152
-13% -$7.32M 0.03% 487
2022
Q3
$53.8M Buy
78,142
+3,415
+5% +$2.35M 0.03% 419
2022
Q2
$44.2M Sell
74,727
-5,003
-6% -$2.96M 0.02% 476
2022
Q1
$55.7M Sell
79,730
-8,693
-10% -$6.07M 0.03% 451
2021
Q4
$55.8M Buy
88,423
+20,763
+31% +$13.1M 0.03% 456
2021
Q3
$40.9M Buy
67,660
+2,908
+4% +$1.76M 0.02% 527
2021
Q2
$36.2M Sell
64,752
-10
-0% -$5.59K 0.02% 559
2021
Q1
$30.6M Buy
64,762
+3,335
+5% +$1.58M 0.02% 566
2020
Q4
$29.7M Sell
61,427
-561
-0.9% -$271K 0.02% 500
2020
Q3
$34.7M Sell
61,988
-227
-0.4% -$127K 0.03% 397
2020
Q2
$38.8M Buy
62,215
+6,278
+11% +$3.92M 0.04% 339
2020
Q1
$27.3M Buy
55,937
+11,309
+25% +$5.52M 0.03% 365
2019
Q4
$16.8M Sell
44,628
-442
-1% -$166K 0.02% 587
2019
Q3
$12.5M Sell
45,070
-756
-2% -$210K 0.01% 657
2019
Q2
$14.3M Sell
45,826
-3,701
-7% -$1.16M 0.02% 585
2019
Q1
$20.3M Sell
49,527
-6,188
-11% -$2.54M 0.03% 445
2018
Q4
$20.8M Buy
55,715
+54,624
+5,007% +$20.4M 0.03% 352
2018
Q3
$441K Sell
1,091
-14,216
-93% -$5.75M ﹤0.01% 946
2018
Q2
$5.28M Sell
15,307
-284
-2% -$98K 0.01% 480
2018
Q1
$5.32M Sell
15,591
-7,264
-32% -$2.48M 0.02% 379
2017
Q4
$8.59M Sell
22,855
-556
-2% -$209K 0.02% 429
2017
Q3
$10.5M Buy
23,411
+95
+0.4% +$42.5K 0.03% 364
2017
Q2
$11.4M Buy
23,316
+2,078
+10% +$1.02M 0.03% 337
2017
Q1
$8.23M Buy
21,238
+5,264
+33% +$2.04M 0.03% 408
2016
Q4
$5.86M Buy
15,974
+2,095
+15% +$769K 0.02% 489
2016
Q3
$5.58M Sell
13,879
-2,925
-17% -$1.18M 0.02% 542
2016
Q2
$5.87M Sell
16,804
-551
-3% -$192K 0.02% 562
2016
Q1
$6.26M Buy
17,355
+1,245
+8% +$449K 0.03% 508
2015
Q4
$8.75M Buy
16,110
+1,307
+9% +$710K 0.04% 393
2015
Q3
$6.89M Sell
14,803
-1,975
-12% -$919K 0.03% 439
2015
Q2
$8.56M Sell
16,778
-741
-4% -$378K 0.04% 422
2015
Q1
$7.91M Buy
17,519
+16,106
+1,140% +$7.27M 0.04% 428
2014
Q4
$580K Sell
1,413
-31
-2% -$12.7K 0.01% 678
2014
Q3
$521K Buy
1,444
+13
+0.9% +$4.69K 0.01% 773
2014
Q2
$404K Buy
1,431
+47
+3% +$13.3K ﹤0.01% 820
2014
Q1
$416K Buy
1,384
+332
+32% +$99.8K ﹤0.01% 700
2013
Q4
$290K Buy
1,052
+230
+28% +$63.4K ﹤0.01% 742
2013
Q3
$257K Buy
822
+58
+8% +$18.1K ﹤0.01% 743
2013
Q2
$172K Buy
+764
New +$172K ﹤0.01% 826